CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026
Go back to CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026| CytoDyn, Inc. (AMEX: CYDY) | Delayed: 0.26 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.26 | 52 Week High | $1.57 | |||
| Open | $0.26 | 52 Week Low | $0.61 | |||
| Day High | $0.26 | P/E | N/A | |||
| Day Low | $0.26 | EPS | $0.00 | |||
| Volume | 1,658,418 | |||||

